Stay updated on Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-31T13:12:24.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    A notice was added stating that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and linking to updates and FAQs.
    Difference
    0.5%
    Check dated 2026-10-24T14:58:48.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer release label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T14:45:08.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The site footer now identifies the ClinicalTrials.gov release as v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-10T15:39:13.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The record history now shows the latest revision as v3.7.0, replacing the previous v3.6.6 label, indicating an update to how the history is versioned or displayed.
    Difference
    0.1%
    Check dated 2026-09-19T18:00:32.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    No additions or deletions are listed for this study history page in the provided data. Consequently, there are no content changes to describe.
    Difference
    0.1%
    Check dated 2026-09-12T17:48:56.000Z thumbnail image

Stay in the know with updates to Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial page.